Here are seven things for ASC leaders to know.
Eli Lilly acquiring CoLucid Pharmaceuticals for $960M
Indianapolis-based Eli Lilly and Co. is acquiring Cambridge, Mass.-based CoLucid Pharmaceuticals for $960 million.
Orphan drugs' annual average price tag cost $88.4k more than mainstream drugs in 2014
The National Institute of Health estimates rare diseases impact nearly 10 percent of all Americans, with orphan drugs often carrying a substantial list price. Through 2020, orphan drugs' annual sales are likely to increase 12 percent each year. The average annual price tag for orphan drugs totaled $111,820 in 2014. Comparatively, mainstream drugs cost $23,331, on average, that year
The ACA hits peak popularity, despite looming repeal
Despite a possible repeal of the ACA looming, Americans responded positively about President Barack Obama's health law. Forty-five percent of respondents said the ACA is a "good idea," while the remaining 41 percent said the law was a bad idea.
84% of medical personnel are unsure of MACRA's requirements, survey finds
Providers spanning the nation are unsure about what CMS' Medicare Access and CHIP Reauthorization Act will require of their practice.
Judge expected to block Anthem-Cigna merger
U.S. District of Columbia Judge Amy Berman Jackson is expected to block the pending merger between Indianapolis-based Anthem and Bloomfield, Conn.-based Cigna.
National Quality Foundation taps Dr. Shantanu Agrawal as new president and CEO
The Washington, D.C.-based National Quality Forum selected Shantanu Agrawal, MD, as its next president and CEO.
359k physicians to participate in CMS' Alternative Payment Models in 2017
CMS announced that 359,000 physicians intend to participate in four of CMS' Alternative Payment Models in 2017.